China's pharmaceutical scale exceeds 1 trillion, up 18% year on year

Source: hexun.com held an information conference on China's pharmaceutical retail industry in Boao on August 20, 2014, and released the "blue book on the analysis of China's six terminal pharmaceutical markets (2013-2014)" (hereinafter referred to as the "blue book") (for more exclusive financial news, please add the micro signal CBN Yicai) according to the blue book data, in 2013, the total scale of the whole Chinese medicine (600056, stock bar) market reached 1146.3 billion yuan, an increase of 18% compared with the previous year and an annual growth rate of 19% It is estimated that by 2014, the scale of China's pharmaceutical market will reach 1332.6 billion yuan, an increase of 16% year on year Wu Han, general manager of Zhongkang information, said that the main driving forces for the growth of the pharmaceutical market are: the government's investment in medical care under the new medical reform policy; the opportunities brought about by GDP growth; the opportunities brought about by the gradual improvement of the medical system; the demand brought about by the aging population and the changes in the disease spectrum; and the formation and improvement of the social financing system In terms of channel distribution, according to the forecast, the market proportion of six major terminals in China's pharmaceutical market in 2014 is respectively: 55% of urban hospitals, 17% of county hospitals, 16% of retail pharmacies, 6% of urban hospitals, 5% of rural hospitals, and 1% of online pharmacies In 2013, there were 442300 pharmacies in China, an increase of 1.5% over 2012 Chain drugstores in China still maintain a low concentration According to the survey results, at present, the sales volume of top 100 direct stores accounts for less than 40% of the total scale, rising slowly It is predicted that the sales volume of top 100 direct stores will account for about 38% in 2014, and there will be a big gap in reaching the goal of 60% in 2015 According to Zhongkang information, single drugstores have more advantages than chain drugstores in terms of labor costs, taxes and other aspects If the pharmaceutical retail chain enterprises do not have substantial growth or policy support in sales, it is difficult to significantly improve the industry concentration in the past five years In the future, under the impact of national medical reform policy, hospital market and online drugstore market, the growth rate of retail drug market will decline According to the data, the retail drug market grew by 12% in 2013, down 4% compared with the previous year In 2013, China's drug retail market reached 257.1 billion yuan, an increase of 11% over 2012 Among them, drug sales reached RMB 202.1 billion, a year-on-year increase of 12%, accounting for 79% of the market share; non drug sales reached RMB 55 billion, a year-on-year increase of 8%, accounting for 21% of the market share It is estimated that in 2014, the scale of China's drug retail market will reach 280.5 billion yuan, up 9% year on year As some cities strictly control the card swiping consumption behavior of non drug categories in Medicare designated drugstores and the gradual fading out of drug make-up brands, the retail sales of non drug categories still maintain a low share From 2009 to 2013, the proportion of drug and non drug sales remained 8:2 Some insiders predict that the growth rate of non drug sales will be faster than that of drugs in 2014, "which is related to the introduction of milk powder management by drugstores to drive the growth of food sales scale." It is reported that in non drug sales, health care products and devices are the largest, accounting for about 70% of non drug sales in total "At present, the food industry has a small base and a rapid growth, and the future is the main driving force for the growth of the whole non drug industry," the person said